Thyroid hormone receptor-β agonist simedeutirom (HSK31679) for Chinese patients with metabolic dysfunction-associated steatohepatitis: a 52-week, multicentre, randomised, double-blind, placebo-controlled, phase 2b trial
1. 文件大小不能超过300M, 允许上传文档或压缩包等
2. 请确保上传文献的真实性、完整性,不得对原文做任何修改
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1016/s2468-1253(26)00243-8
文献链接: https://linkinghub.elsevier.com/retrieve/pii/S2468125326002438
其他信息:
出版社: Elsevier BV
作者: Feng Xue; Jianfeng Liu; Jinjun Chen; Xing Li; Sikui Wang; Yawen Luo; Bangjie Zhang; Jiawei Geng; Weihong Wang; Rui Zhao; Chuanwu Zhu; Junjun Bi; Xiqing Guo; Lungen Lu; Guangming Li; Hong Peng; Li Dong; Weifang Zeng; Tingting Wu; Fangqiong Li; Lai Wei

